Novel Regimen Boosts Survival for Recurrent Platinum-Resistant Ovarian Cancer
MedPage Today) — SAN JUAN, PUERTO RICO — A novel regimen for platinum-resistant ovarian cancer solidified its role as a treatment option with a significant improvement in overall survival (OS), according to a ROSELLA trial update.
Adding…
Read More
